Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Risk Factors for Epilepsy Among Post-9/11 Veterans: Traumatic Brain Injury and Deployment Status
General Neurology
Neuroepidemiology Posters (7:00 AM-5:00 PM)
009

The association of TBI and epilepsy in Veterans has been examined among those with combat deployments. We hypothesized that individuals with epilepsy would be more likely than those without epilepsy to have history of TBI and a history of deployment where blast injury/military exposures are more common.

To identify predictors of epilepsy in Post-9/11 Veterans. 

Retrospective observational study using merged Veterans Health Administration (VHA) and Department of Defense health data (2002-2019) for Veterans who entered VHA care 2002-2014. We identified epilepsy using ICD9/10 codes and use of anti-seizure medications. We identified TBI severity using ICD9/10 codes and TBI screening data, and mental/physical health comorbidities using ICD9/10 codes before the index date (EPILEPSY: date of the first anti-seizure medication after epilepsy-consistent diagnosis; No EPILEPSY: median time from first care in DoD to epilepsy [2625 days]). We excluded individuals with verified psychogenic non-epileptic seizures. We used logistic regression to identify predictors of epilepsy.

In this cohort (N=1,226,280), 30,993 (2.53%) met criteria for epilepsy. After controlling for mental/physical health comorbidities, odds of epilepsy were significantly lower for deployed (vs. non-deployed; AOR 0.76; 0.73-0.79). Compared to individuals without TBI, those with mTBI (OR 1.60; 1.55-1.66), moderate/severe TBI (OR 2.84; 2.36-2.61), penetrating TBI (OR 5.13; 4.71-5.58) had significantly higher odds of epilepsy. Other strong predictors included other neurological conditions such as ALS, MS, Parkinson’s disease (OR 6.73; 6.38-7.10), stroke (OR 3.61; 3.45-3.77), headache/migraine (OR 2.34; 2.28-2.40), and cardiac disease (OR 1.91; 1.84-1.98).

TBI, including mTBI, was associated with epilepsy, but those deployed were LESS likely to develop epilepsy. Chronic physical and mental health conditions that preclude deployment were associated with epilepsy and may be of equal concern to clinicians caring for patients with epilepsy and/or TBI; however more sophisticated statistical models are needed to better understand the interactions among TBI, deployment and chronic mental/physical comorbidities.

Authors/Disclosures
Mary Jo Pugh, PhD, RN, FAAN
PRESENTER
The institution of Dr. Pugh has received research support from Department of Defense, Epilepsy Research Program. The institution of Dr. Pugh has received research support from VA Health Services Research and Development Service. The institution of Dr. Pugh has received research support from VA Rehabilitation Research and Development Service. The institution of Dr. Pugh has received research support from Congressionally Directed Research Programs. The institution of Dr. Pugh has received research support from Sanofi.
Christine B. Baca, MD, FAAN (Virginia Commonwealth University) Dr. Baca has nothing to disclose.
Maria Raquel Lopez, MD (University of Miami/VAH) Dr. Lopez has nothing to disclose.
Hamada H. Altalib, DO (VA Connecticut Healthcare System) The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from Eisai. The institution of Dr. Altalib has received research support from Sunovian. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Alan R. Towne, MD, MPH (Virginia Commonwealth Univ/Richmond VA Medical Center) The institution of Dr. Towne has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Towne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Towne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Towne has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Towne has received research support from DOD.
Sidney Hinds, MD, FAAN (SCS Consulting, LLC) An immediate family member of Dr. Hinds has received personal compensation for serving as an employee of Henry Jackson Foundation. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otolith. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ICON. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Consultant for The Conafay Group. Dr. Hinds has received research support from Uniformed Service University. Dr. Hinds has received personal compensation in the range of $500-$4,999 for serving as a Panel member with Congressionally Directed Medical Research Program. Dr. Hinds has a non-compensated relationship as a Ex Offcio Board member with NINDS/NANDS that is relevant to AAN interests or activities.
Megan Amuan No disclosure on file
No disclosure on file
No disclosure on file
Anne C. Van Cott, MD, FAAN (VA Pittsburgh Healthcare System/University of Pittsburgh) Dr. Van Cott has nothing to disclose.